Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
NCT05128149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-04-13
Summary
Treatment of PKU implies for most patients that with strict adherence to dietary treatment they can achieve excellent neurocognitive outcome. Dietary treatment, though, is hard to comply to every day and with every single meal. Unsurprisingly, health-related quality of life (HrQol) is negatively affected if patients have to follow a dietary regime of this kind. Adherence to treatment in PKU is very variable. Factors of significant impact on adherence to treatment and well-being in chronic disease such as self-efficacy or parenting stress have not yet been widely investigated in PKU patients.
The ideal treatment prescription (and guideline) recommends as much as necessary and as little as possible, based on the best evidence available. Patients should neither be deprived of treatment options nor be exposed to overtreatment.
This study investigates adherence, metabolic control, HrQol in PKU patients treated by centres which follow different guidelines
Conditions
- Phenylketonurias
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
UChildrenVienna
collaborator UNKNOWN -
University Children's Hospital Basel
collaborator OTHER -
Insel Gruppe AG, University Hospital Bern
collaborator OTHER -
University Children's Hospital, Zurich
lead OTHER
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-15
- Primary Completion
- 2025-03-30
- Completion
- 2025-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
NCT02261753 ·Status: TERMINATED ·Phase: NA
-
Ketogenic Diet Program for Epilepsy
NCT02497105 ·Status: COMPLETED ·Phase: NA
-
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
NCT01278966 ·Status: COMPLETED ·Phase: NA
-
Physical Excercise Program in Children With Drug-resistant Epilepsy
NCT05323682 ·Status: UNKNOWN ·Phase: NA
-
Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria
NCT06901323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy
NCT00564915 ·Status: COMPLETED ·Phase: PHASE4
-
Market Research - Acceptability Study for a New PKU Protein Substitute
NCT04318509 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet for Child Epilepsy and Seizure Control
NCT00004729 ·Status: COMPLETED ·Phase: NA
-
The Effects of Breakfast on Neuropsychological Functioning
NCT01943604 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
NCT06554288 ·Status: RECRUITING ·Phase: PHASE1
-
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754 ·Status: NOT_YET_RECRUITING
-
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
NCT02000960 ·Status: UNKNOWN ·Phase: PHASE2
-
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
NCT01795170 ·Status: WITHDRAWN
-
Efficacy of Quetiapine for Pediatric Delirium
NCT02056171 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
NCT02624817 ·Status: COMPLETED ·Phase: PHASE4
-
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
NCT04545346 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
NCT05279118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04274179 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
NCT00607542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
NCT06637514 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin in Children With Motor Deficit
NCT00720161 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500 ·Status: RECRUITING ·Phase: NA
-
Response to Phenylketonuria to Tetrahydrobiopterin (BH4)
NCT00244218 ·Status: TERMINATED ·Phase: PHASE1
-
The Ketogenic Diet for Pediatric Acute Brain Injury
NCT02174016 ·Status: SUSPENDED ·Phase: NA